Sclerosol

   
Google
 
Web NewDrugInformation.com

Sclerosol


Drug - Sclerosol
The trade name of the product as shown on the labeling.

Dosage - AEROSOL, METERED; INTRAPLEURAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Talc
Multiple ingredients are in alphabetical order.

Strength - 400MG/SPRAY
The potency of the active ingredient(s), Talc. May repeat for multiple part products.

Applicant - BRYAN
The firm name holding legal responsibility for Sclerosol. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020587
The FDA assigned number to Sclerosol. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Sclerosol. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 24, 1997
The date Sclerosol was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Sclerosol. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Sclerosol is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bryan Corp
The full name of the firm holding legal responsibility for the new application of Sclerosol.

Sclerosol